EUVIMEDEUVIMED entdecken
Crossref

Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology

Emily Alouani, Ariane Laparra, Audrey Perret, Madonna Sakkal, Sabine Messayke, Francois-Xavier Danlos, Kaissa Ouali, Antoine Hollebecque, Caroline Even, Samy Ammari, Capucine Baldini, Stéphane Champiat und 7 weitere

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.113313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Emily Alouani und 18 weiteren Autor:innen. Beteiligte Einrichtung: Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France; Digestive Medical Oncology De…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Mycophenolic Acid, Immunosuppressive Agents, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsMycophenolic AcidImmunosuppressive AgentsChemical and Drug Induced Liver InjuryNeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultRisk FactorsAged, 80 and over

Stichwörter der Autor:innen

Immune-checkpoint inhibitorImmune-related adverse eventsImmune-related hepatitisMycophenolate mofetilSteroids

Substanzen

Immune Checkpoint InhibitorsMycophenolic AcidImmunosuppressive Agents

Autor:innen und Institutionen

  • Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France; Digestive Medical Oncology Department, IUCT-Rangueil, Toulouse Hospital University, Toulouse, Franc…
  • Département Interdisciplinaire d'Organisation des Parcours Patients, Gustave Roussy - Paris-Saclay University, Villejuif, France.
  • Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France.
  • Pharmacovigilance Unit, Gustave Roussy - Paris-Saclay University, Villejuif, France.
  • Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France; INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France.
  • Department of Medical Oncology, Gustave Roussy - Paris-Saclay University, Villejuif, France.

Zitieren

APA

Alouani, E., Laparra, A., Perret, A., Sakkal, M., Messayke, S., Danlos, F. X., Ouali, K., Hollebecque, A., Even, C., Ammari, S., Baldini, C., Champiat, S., Besse, B., Robert, C., Guettier, C., Samuel, D., Lambotte, O., De Martin, E., & Michot, J. M. (2023). Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113313

Vancouver

Alouani E, Laparra A, Perret A, Sakkal M, Messayke S, Danlos FX, et al. Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113313

BibTeX
@article{Alouani2023,
  author = {Alouani, Emily and Laparra, Ariane and Perret, Audrey and Sakkal, Madonna and Messayke, Sabine and Danlos, Francois-Xavier and Ouali, Kaissa and Hollebecque, Antoine and Even, Caroline and Ammari, Samy and Baldini, Capucine and Champiat, Stéphane and Besse, Benjamin and Robert, Caroline and Guettier, Catherine and Samuel, Didier and Lambotte, Olivier and De Martin, Eleonora and Michot, Jean-Marie},
  title = {Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.113313}
}
Kostenlos starten →